Erdogan-Trinkaus Ipek
SEC CIK 2047026 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | Chief Commercial Off | 2,403 | — | — | 1 | 2025-12-12 | 2025-12-12 |
Most active insiders at ETON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | — | $9.91M |
| 2 | Opaleye Management Inc. | 10% | — | $6.89M |
| 3 | MAIER PAUL V | Dir | — | $5.91M |
| 4 | Krempa David | Chief Business Off | — | $4.86M |
| 5 | Adams Jennifer McKie | Dir | — | $1.62M |
| 6 | Erdogan-Trinkaus Ipek | Chief Commercial Off | — | — |
| 7 | Gruber James R. | CFO | — | — |
| 8 | RIEDEL NORBERT G | Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-12 | ETON | Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Off | F - Tax | $16.90 | -85 | 2,403 | -3% | -$1,436 |
Purchase Sale Sale after option exercise All abbreviations